| dc.contributor.author | DEGAREGE (, MASTEWAL | |
| dc.date.accessioned | 2026-10-23T06:41:57Z | |
| dc.date.available | 2026-10-23T06:41:57Z | |
| dc.date.issued | 2025-03 | |
| dc.identifier.uri | http://ir.bdu.edu.et/handle/123456789/17581 | |
| dc.description.abstract | Background: Chronic liver disease is the gradual distraction of liver tissue. The risk factors for Chronic liver disease may vary in different population. In Ethiopia the main causative agents of chronic liver disease are hepatitis B and C viruses and alcohol. Hepatitis B virus (HBV) infected patients with a positive Hepatitis B e- antigen (HBeAg) result indicates the presence of active replication and high infectivity. Determining the prevalence of HBV infection and HBeAg among CLD patients in each region is essential for managing the diseases and designing healthcare strategies. Objective: The aim of this study is to determine the prevalence of HBsAg, HBeAg, and associated risk factors among patients with chronic and suspected liver disease in in Bahir Dar Governmental Specialized Hospitals, Amhara National Regional State, North west Ethiopia. Methods: A cross-sectional study design was conducted among 384 patients with chronic and suspected liver disease who visited Governmental specialized hospitals from June to August 2024. Socio-demographic and associated risk factor data were collected using a structured questionnaire. Five ml of blood sample was collected from each study participant. ELISA and Maglumi HBeAg kits were used to detect HBsAg and HBeAg respectively. The results were analyzed using SPSS version 27. Results: The total prevalence of HBsAg was 34.9 %( 134/384; 95% CI; 30.1-39.9), among CLD, and in suspected liver disease patients were 50.5% (95/188) and 19.9% (39/196), respectively. The overall prevalence HBeAg was 35.1% (47/134; 95% CL; 27.0-43.8). The prevalence of HBeAg among chronic and suspected liver disease patients was 37.9% (36/95) and 28.2% (11/39), respectively. High prevalence of HBsAg and HBeAg was found among male and frequent alcohol user study participants. History of hospital admission (AOR=2.736 (95% CI=1.66-4.50)) and contact with jaundiced patients (AOR=2.3 (95% CI=1.36-3.81)) had a statistically significant association with HBV infection. Conclusion: Half of CLD patients were infected with HBV. More than 30% of them were positive for HBeAg. HBsAg and HBeAg were high among males with a history of hospital admission and contact with jaundice patients. We recommended chronic HBV-infected and suspected liver disease patients should be screened for HBeAg, and early management of the diseases is mandatory to prevent liver cancer and transmission of HBV infection. | en_US |
| dc.subject | Chronic liver disease, HBsAg, HBeAg, Ethiopia | en_US |
| dc.title | PREVALENCE OF HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG), HEPATITIS B-E ANTIGEN (HBEAG) AND ASSOCIATED FACTORS AMONG CHRONIC AND SUSPECTED LIVER DISEASE PATIENTS IN BAHIR DAR GOVERNMENTAL SPECIALIZED HOSPITALS, AMHARA NATIONAL REGIONAL STATE, NORTH WEST ETHIOPIA | en_US |
| dc.type | Thesis | en_US |